Alicia R Folgueras Selected Research

Alicia R Folgueras Research Topics

Disease

9	Neoplasms (Cancer) 01/2018 - 01/2004
3	Carcinoma (Carcinomatosis) 01/2018 - 04/2008
3	Lung Neoplasms (Lung Cancer) 01/2018 - 05/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2010
2	Obesity 10/2018 - 06/2004
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 04/2008
2	Skin Neoplasms (Skin Cancer) 01/2018 - 06/2004
2	Hyperalgesia 05/2017 - 09/2009
2	Pathologic Processes 01/2010 - 06/2004
1	Premature Aging 10/2023
1	Progeria (Hutchinson Gilford Syndrome) 01/2019
1	Insulin Resistance 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Fibrosarcoma 01/2018
1	Adenocarcinoma 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2017
1	Infections 01/2017
1	Arthritis (Polyarthritis) 01/2010
1	Pain (Aches) 09/2009
1	Inflammation (Inflammations) 09/2009
1	Iron-Refractory Iron Deficiency Anemia 06/2009
1	Anemia 06/2009
1	Alopecia (Baldness) 09/2008
1	Wounds and Injuries (Trauma) 09/2008
1	Melanoma (Melanoma, Malignant) 04/2008
1	Lymphatic Metastasis 04/2008
1	Breast Neoplasms (Breast Cancer) 04/2008
1	Neoplasm Metastasis (Metastasis) 04/2008
1	Multiple Sclerosis 04/2008
1	Hypertrophy 06/2004
1	Rheumatoid Arthritis 06/2004

Drug/Important Bio-Agent (IBA)

8	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2004
6	EnzymesIBA 01/2018 - 01/2004
3	IronIBA 10/2018 - 09/2008
3	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2018 - 04/2008
3	CarcinogensIBA 05/2013 - 06/2004
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2008
2	matriptase 2IBA 10/2018 - 06/2009
2	HepcidinsIBA 10/2018 - 06/2009
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 06/2009
2	LigandsIBA 01/2017 - 02/2016
2	Metalloproteases (Metalloproteinases)IBA 09/2009 - 04/2008
2	matrix metalloproteinase 19IBA 05/2006 - 06/2004
1	ProteomeIBA 10/2023
1	Blood Proteins (Serum Proteins)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2018
1	ProstaglandinsIBA 05/2017
1	capsazepineIBA 05/2017
1	SC 560IBA 05/2017
1	CCR5 Receptors (CCR5 Receptor)IBA 05/2017
1	D-Ala-peptide T-amideIBA 05/2017
1	Celecoxib (Celebrex)FDA Link 05/2017
1	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 05/2017
1	UCB 35625IBA 05/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2017
1	Diclofenac (SR 38)FDA LinkGeneric 05/2017
1	Casein Kinase II (Casein Kinase 2)IBA 01/2017
1	InterferonsIBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	CytokinesIBA 02/2016
1	ZincIBA 01/2010
1	EndopeptidasesIBA 01/2010
1	Cadherins (E-Cadherin)IBA 09/2009
1	Dextrans (Dextran)FDA Link 09/2008
1	Tyrosine (L-Tyrosine)FDA Link 09/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2008
1	Caveolin 1IBA 09/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2008
1	Matrix Metalloproteinase 13IBA 09/2008
1	matrigelIBA 04/2008
1	Extracellular Matrix ProteinsIBA 04/2008
1	Matrix Metalloproteinase InhibitorsIBA 01/2004

Therapy/Procedure

5	Therapeutics 01/2019 - 01/2004